News: IMC Immuron US DoD Naval Medical Research Center Receives Feedback On on IND Application For...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    July 26 (Reuters) - Immuron Ltd (IMC) :

    • IMMURON US DOD NAVAL MEDICAL RESEARCH CENTER RECEIVES FEEDBACK ON IND APPLICATION FOR NEW CAMPYLOBACTER ETEC THERAPEUTIC
    • IMMURON LTD - RECEIVED FEEDBACK FROM U.S. FDA AFTER REVIEW OF IND FOR A NEW ORAL THERAPEUTIC TARGETING CAMPYLOBACTER AND ETEC
    • IMMURON - AGENCY SPECIFIED IND DOES NOT CONTAIN SUFFICIENT INFORMATION REQUIRED UNDER 21 CFR 312.23 TO ASSESS RISK TO SUBJECTS IN PROPOSED STUDIES
    • IMMURON - IND PLACED ON CLINICAL HOLD UNTIL FDA HAVE RECEIVED, REVIEWED RESPONSE FROM NMRC JUSTIFYING DOSING, SAFETY MONITORING, RISK MITIGATION PLAN
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.0¢
Change
0.001(1.45%)
Mkt cap ! $18.77M
Open High Low Value Volume
6.8¢ 7.0¢ 6.8¢ $16.84K 244.6K

Buyers (Bids)

No. Vol. Price($)
1 10000 6.8¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 148417 1
View Market Depth
Last trade - 16.10pm 11/09/2025 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.